跳至主要内容
临床试验/NCT05675670
NCT05675670进行中(未招募)不适用

Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Hyperthyroidism

National Defense Medical Center, Taiwan1 个研究点 分布在 1 个国家目标入组 35,000 人开始时间: 2023年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
35,000
试验地点
1
主要终点
New-onset hyperthyroidism

研究概览

简要总结

hyperthyroidism

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients in outpatient department.
  • •Patients recieved at least 1 ECG examination.
  • •Patients without TSH test before ECG examination or patients with subclinical hyperthyroidism without anti-thyroid drug usage.

排除标准

  • •The patients recieved ECG at the period of inactive AI-ECG system.

研究组 & 干预措施

Intervention

Experimental

Patients randomized to intervention will have access to the screening tool

干预措施: AI-enabled ECG-based Screening Tool (Other)

Control

No Intervention

Patients randomized to control will continue routine practice.

结局指标

主要结局

New-onset hyperthyroidism

时间窗: Within 30 days

A TSH of \<0.25 IU/L

New-onset anti-throid drug treatment

时间窗: Within 60 days

New anti-throid drug treatment for patients with subclinical hyperthyroidism

次要结局

  • Cardiac event(Within 1 year.)
  • All-cause mortality(Within 1 year.)

研究者

发起方
National Defense Medical Center, Taiwan
申办方类型
Other
责任方
Principal Investigator
主要研究者

Chin Lin

Assistant Professor

National Defense Medical Center, Taiwan

研究点 (1)

Loading locations...

相似试验